Your browser doesn't support javascript.
loading
A longitudinal hospital-based epidemiology study to assess acute otitis media incidence and nasopharyngeal carriage in Korean children up to 24 months.
Lee, Jin; Kim, Ki Hwan; Jo, Dae Sun; Ma, Sang Hyuk; Kim, Jong-Hyun; Kim, Chun Soo; Kim, Hwang Min; Kang, Jin Han.
Afiliação
  • Lee J; Department of Pediatrics, Hanil General Hospital , Seoul, Republic of Korea.
  • Kim KH; Department of Pediatrics, Incheon St. Mary's Hospital, The Catholic University of Korea , Incheon, Republic of Korea.
  • Jo DS; Department of Pediatrics, Chonbuk National University Children's Hospital , Jeonju, Republic of Korea.
  • Ma SH; Department of Pediatrics, Changwon Fatima Hospital , Changwon, Republic of Korea.
  • Kim JH; Department of Pediatrics, St. Vincent's Hospital, the Catholic University of Korea , Suwon, Republic of Korea.
  • Kim CS; Department of Pediatrics, Dongsan Medical Center, Keimyung University School of Medicine , Daegu, Republic of Korea.
  • Kim HM; Department of Pediatrics, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine , Wonju, Republic of Korea.
  • Kang JH; Department of Pediatrics, Seoul St. Mary's Hospital, The Catholic University of Korea , Seoul, Republic of Korea.
Hum Vaccin Immunother ; 16(12): 3090-3097, 2020 12 01.
Article em En | MEDLINE | ID: mdl-32330397
ABSTRACT
This study was conducted to assess the nasopharyngeal (NP) carriage and acute otitis media (AOM) occurrence in Korean children who received pneumococcal conjugate vaccines (PCVs). The longitudinal study was conducted through four consecutive visits. At each visit, NP aspirates were obtained and subjects were asked to visit if AOM occurred. A total of 305 subjects were enrolled and received PCV13 (n = 182) or PCV10 (n = 123). In the PCV13 group, the NP carriage of Streptococcus pneumoniae at each visit was 2.7%, 14.8%, 18.7%, and 15.9%, respectively. Non-typeable Haemophilus influenzae (NTHi) was 3.3%, 2.7%, 2.7%, and 5.5%, and that of Moraxella catarrhalis was 1.1%, 9.3%, 4.9%, and 0.5%. In the PCV10 group, the NP carriage of S. pneumoniae at each visit was 3.3%, 7.3%, 6.5%, and 4.1%, respectively. That of NTHi was 2.4%, 4.1%, 1.6%, and 0.8%, and that of M. catarrhalis was 4.1%, 0.8%, 0.8%, and 0.0%. AOM occurrence in the PCV13 group observed after the primary dose and before booster dose was 20.9%, occurrence after booster dose was 11.0%, and the incidence of two or more AOM was 11.0%. In the PCV10 group, AOM occurrence was 9.8%, 7.3%, respectively, and the incidence of two or more AOM was 2.4%. The predominant S. pneumoniae isolated were non-vaccine type (10A, 15A, and 15B). In this study, AOM occurrence was lower in the PCV10 group than in the PCV13 group. This seems to be related to ecological changes that lead to differences in NP carriage, especially S. pneumoniae and NTHi.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Otite Média / Infecções Pneumocócicas / Nasofaringe / Vacinas Pneumocócicas Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Otite Média / Infecções Pneumocócicas / Nasofaringe / Vacinas Pneumocócicas Idioma: En Ano de publicação: 2020 Tipo de documento: Article